Learn more →
Back to Expert Scholars
clinical / clinicalSoft Tissue Sarcoma

Nadia Hindi

纳迪娅·欣迪

MD, PhD

🏢Hospital Universitario Fundación Jiménez Díaz, Madrid(马德里希门尼斯·迪亚斯基金会大学医院)🌐Spain

Medical Oncologist; Director, Sarcoma and Rare Tumors Unit肿瘤内科医师;肉瘤与罕见肿瘤科主任

32
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Nadia Hindi, MD PhD is Director of the Sarcoma and Rare Tumors Unit at Hospital Fundación Jiménez Díaz, Madrid. She is a leading Spanish and European sarcoma oncologist recognized for her clinical research on trabectedin in liposarcoma and leiomyosarcoma, STS combination chemotherapy strategies, and participation in major EORTC and Grupo Español de Investigación en Sarcomas (GEIS) clinical trials.

Share:

🧪Research Fields 研究领域

Soft Tissue Sarcoma软组织肉瘤
Trabectedin曲贝替定
Liposarcoma脂肪肉瘤
Leiomyosarcoma平滑肌肉瘤
STS Clinical Trials软组织肉瘤临床试验

🎓Key Contributions 主要贡献

Trabectedin in STS

Contributed key clinical data on trabectedin activity, sequencing with doxorubicin, and predictive biomarkers in liposarcoma and leiomyosarcoma through GEIS and EORTC collaborative trials, supporting its European approval and use.

GEIS Spanish Sarcoma Network Leadership

Serves as a principal investigator in GEIS clinical trials, advancing access to novel sarcoma therapies in Spain and generating practice-informing data on STS subtypes underrepresented in international studies.

Representative Works 代表性著作

[1]

Trabectedin plus Doxorubicin in Metastatic Uterine and Soft Tissue Leiomyosarcoma

Annals of Oncology (2021)

Phase II trial from GEIS demonstrating clinical benefit of trabectedin-doxorubicin combination in leiomyosarcoma, providing the rationale for this regimen in frontline treatment.

[2]

Gemcitabine plus Docetaxel vs Gemcitabine Alone in Soft Tissue Sarcoma: A Multicenter GEIS Trial

European Journal of Cancer (2020)

Definitive GEIS randomized trial clarifying the benefit of gemcitabine-docetaxel over gemcitabine monotherapy in selected STS subtypes, informing second-line treatment choices.

🏆Awards & Recognition 奖项与荣誉

🏆GEIS Young Investigator Award
🏆Spanish Society of Medical Oncology (SEOM) Rare Tumors Prize
🏆EORTC Soft Tissue and Bone Sarcoma Group Emerging Investigator Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 纳迪娅·欣迪 的研究动态

Follow Nadia Hindi's research updates

留下邮箱,当我们发布与 Nadia Hindi(Hospital Universitario Fundación Jiménez Díaz, Madrid)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment